Skip to Content

Hydrocortisone Sodium Succinate Injection

Last Updated: November 26, 2014
Status: Resolved

Products Affected - Description

A-Hydrocort, Hospira
100 mg vial (NDC 00409-4856-05)

Reason for the Shortage

  • Hospira has A-Hydrocort on shortage due to requirements related to good manufacturing practices.
  • Pfizer had Solu-Cortef on shortage due to manufacturing delays.

Available Products

Solu-Cortef, Pfizer
100 mg plain vial (NDC 00009-0825-01)
100 mg/2 mL, preservative-free Act-O-Vial, 1 count (NDC 00009-0011-03)

100 mg/2 mL, preservative-free Act-O-Vial, 25 count (NDC 00009-0011-04)
250 mg/2 mL, preservative-free Act-O-Vial, 1 count (NDC 00009-0013-05)
250 mg/2 mL, preservative-free Act-O-Vial, 25 count (NDC 00009-0013-06)
500 mg, preservative-free Act-O-Vial (NDC 00009-0016-12)
1000 mg, preservative-free Act-O-Vial (NDC 00009-0005-01)

Estimated Resupply Dates

  • Hospira has A-Hydrocort 100 mg vials on long-term back order and the company cannot estimate a release date.
  • Pfizer has been supplying the market with Solu-Cortef for several months.

Related Shortages

Updated

November 26, 2014; October 23, 2014; August 27, 2014; June 30, 2014; April 22, 2014; April 9, 2014; March 24, 2014; March 14, 2014; March 11, 2014; February 3, 2014; January 13, 2014; October 14, 2013; July 25, 2013; May 13, 2013; February 28, 2013; November 29, 2012; August 17, 2012; June 19, 2012; May 30, 2012; May 24, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide